Excellent results in terms of weight loss and Type 2 Diabetes control are maintained 20 years after Roux-en-Y gastric bypass. Lapena-Rodriguez M, Cassinello-Fernandez N, Alfonso-Ballester R, Marti-Fernandez RM, Civera-Andres M, Ortega-Serrano J. Journal of Gastrointestinal Surgery. 2023 Nov;27(11):2580-2582. doi: 10.1007/s11605-023-05734-5. PMID: 37430093

Expert recommendations for using time-in-range and other continuous glucose monitoring metrics to achieve patient-centered glycemic control in people with diabetes. Bellido V, Aguilera E, Cardona-Hernandez R, Diaz-Soto G, Gonzalez Perez de Villar N, Picon-Cesar MJ, Ampudia-Blasco FJ. Journal of Diabetes Science and Technology. 2023 Sep;17(5):1326-1336. doi: 10.1177/19322968221088601. PMID: 35470692

How macronutrients and pancreatic enzyme supplements dose variability affect fat, protein and starch absorption in children with cystic fibrosis. Larriba R, Roca M, Masip E, Canada-Martinez A, Ribes-Koninckx C, Calvo-Lerma J. Digestive and Liver Disease. 2023 Apr;55(4):513-518. doi: 10.1016/j.dld.2022.11.006. PMID: 36435715

Impact of conducting a genetic study on the management of familial hypercholesterolemia. Marco-Benedi V, Cenarro A, Vila A, Real J, Tamarit J, Walther L, Diaz-Diaz J, Perea V, Civeira F, Vaz A. Journal of Clinical Lipidology. 2023 Nov-Dec;17(6):717-731. doi: 10.1016/j.jacl.2023.08.008. PMID: 37813710

Low muscle mass is associated with poorer glycemic control and higher oxidative stress in older patients with type 2 Diabetes. Alabadi B, Civera M, De la Rosa A, Martinez-Hervas S, Gomez-Cabrera M, Real J. Nutrients. 2023 Jul 17;15(14):3167. doi: 10.3390/nu15143167. PMID: 37513585

Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells. Francisco V, Eldjoudi D, Gonzalez-Rodriguez M, Ruiz-Fernandez C, Cordero-Barreal A, Marques P, Sanz M, Real J, Lago F, Pino J, Farrag Y, Gualillo O. Spine Journal. 2023 Oct;23(10):1549-1562. doi: 10.1016/j.spinee.2023.06.005. PMID: 37339697

Overview of cellular and soluble mediators in systemic inflammation associated with non-alcoholic fatty liver disease. Marques P, Francisco V, Martinez-Arenas L, Carvalho-Gomes A, Domingo E, Piqueras L, Berenguer M, Sanz M. International Journal of Molecular Sciences. 2023 Jan 24;24(3):2313. doi: 10.3390/ijms24032313. PMID: 36768637

Physical activity patterns in type 1 diabetes in Spain: The SED1 study. Gómez-Peralta F, Menéndez E, Conde S, Conget , Novials A, Olmedo I, Tinahones F, San Laureano F, de la Torre M, Carazo A, Hospital J, Nivela O, Menendez E, Cosmas L, Payeras F, Gómez I, Bayo J, Montalbán C, Gomez-Peralta F, de Luis D, Díaz-Soto G, López-Guzmán A, Santos-Mazo E, Jimenez L, Alvarez V, Samper B, Ballesteros A, Gómez B, Conget I, Perez-Maraver M, Soldevila B, Flores I, García M, Ricart W, Colet A, Biescas E, Ampudia-Blasco F, Hernandez-Mijares A, Sanchez-Juan C, Picó A, Escribano J, Montañana C, Pedro T, Abellán P, Rossetti P, Morales-Pérez F, Enciso F, González A, Guerrero D, Cano R, López J, Melero V, Martín J, Mira S, Serrano M, Sanfiel M, Pascual A, Gómez F, Fernández M, Illán F, Martínez A, Llenas L, Gaztambide S, Gómez C, Oleaga A, de Salinas M, López-Siguero J, Gómez-Gila A, Sancho A, Lozano M, Galán I, Caimari M, Cardona R, León M, González G, Diez F, Rodríguez P, Roldán B, del Villar N, Pérez P, Rica I, López I. BMC Sports Science Medicine and Rehabilitation. 2023 Jul 26;15(1):92. doi: 10.1186/s13102-023-00695-3. PMID: 37491278

Real-world evaluation of GLP-1 receptor agonist therapy persistence, adherence and therapeutic inertia among obese adults with Type 2 Diabetes. Palanca A, Ampudia Blasco F, Calderon J, Sauri I, Martinez Hervas S, Trillo J, Redon J, Real J. Diabetes Therapy. 2023 Apr;14(4):723-736. doi: 10.1007/s13300-023-01382-9. PMID: 36847952

Remission of graves disease after initiation of ocrelizumab in patients with multiple sclerosis. Casany-Fernandez R, Gascon-Gimenez F, Matarredona Solaz E, Pardo Lozano F, Dominguez-Moran J, Ferri Ciscar J, Real J. Thyroid. 2023 Feb;33(2):267-269. doi: 10.1089/thy.2022.0398. PMID: 36416241

Spanish Consensus on the use of isCGM in the management of patients with insulin therapy: the MONITOR Project. Ampudia-Blasco F, Ugarte-Abasolo E, Chico A, Garcia-Aleman J, Galan-Barroso M. Journal of Diabetes Science and Technology. 2023 Sep;17(5):1256-1264. doi: 10.1177/19322968221087270. PMID: 35466722

Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor. Martin-Vano S, Miralles-Abella A, Castano P, Hurtado-Genoves G, Aguilar-Ballester M, Herrero-Cervera A, Vinue A, Martinez-Hervas S, Gonzalez-Navarro H. Clinica e Investigacion en Arteriosclerosis. 2023 Jan-Feb;35(1):1-11. English, Spanish. doi: 10.1016/j.arteri.2022.05.003. PMID: 35738949

Which people with diabetes are treated with a disposable, half-unit insulin pen? A real-world, retrospective, database study in Spain. Ampudia-Blasco F, Duque N, Artime E, Caveda E, Spaepen E, Diaz-Cerezo S, de Santos M, Velasco D, Bahillo-Curieses M. Endocrinology, Diabetes & Metabolism. 2023 Nov;6(6):e451. doi: 10.1002/edm2.451. PMID: 37715339

Developing a simple and practical decision model to predict the risk of incident type 2 diabetes among the general population: The Di@bet.es Study. Martinez-Hervas S, Morales-Suarez-Varela MM, Andres-Blasco I, Lara-Hernandez F, Peraita-Costa I, Real JT, Garcia-Garcia AB, Chaves FJ. European Journal of Internal Medicine. 2022 Aug;102:80-87. doi: 10.1016/j.ejim.2022.05.005. PMID: 35570127

Diabetes and the WHO Model List of Essential Medicines. Danne T, Ampudia-Blasco FJ, Mathieu C. Lancet Diabetes & Endocrinology. 2022 Jan;10(1):18-19. doi: 10.1016/S2213-8587(21)00322-3. PMID: 34919865

Effect of personality on blood glucose control in patients with type 1 diabetes. Gu Hong W, Ferri J, Ampudia-Blasco F, Martin-Brufau R, Peiro M, Benito E, Martinez-Hervas S, Sanz M, Real J. Endocrinologia, Diabetes y Nutricion. 2022 Nov;69(9):677-685. doi: 10.1016/j.endien.2021.11.034. PMID: 36470643

Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study. D’Erasmo L, Steward K, Cefalu A, Di Costanzo A, Boersma E, Bini S, Arca M, van Lennep J, Real Collado J, Italian and European Working Group on Lomitapide in HoFH. European Journal of Preventive Cardiology. 2022 May 5;29(5):832-841. doi: 10.1093/eurjpc/zwab229. PMID: 34971394

Efficacy of long-term treatment of autosomal recessive hypercholesterolemia with lomitapide: a subanalysis of the Pan-European Lomitapide Study. D’Erasmo L, Giammanco A, Suppressa P, Pavanello C, Iannuzzo G, Di Costanzo A, Tramontano D, Minicocci I, Bini S, Vogt A, Stewards K, Van Lennep J, Bertolini S, Arca M. Frontiers in Genetics. 2022 Aug 22;13:937750. doi: 10.3389/fgene.2022.937750. PMID: 36072671

First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO). Pérez Pérez A, Ortega Martínez de Victoria E, Arrieta Blanco F, Caixàs Pedragós A, Santos Mazo E, Fernandez-Catalina P, Martínez-Hervas S, López-Medina JA, Suárez-Gutiérrez L, Urgeles Planelles JR, Gatell Menchén S, Tinahones Madueño F. Endocrinologia, Diabetes y Nutrición. 2022 Aug-Sep;69(7):540-542. doi: 10.1016/j.endien.2021.07.002. PMID: 35995680

Immune-mediated necrotising inflammatory myopathy. A rare side effect of statins. Alarcon Chulilla M, Avila Fuentes M, Casan Fernandez R, Muelas N, Real Collado J. Endocrinologia, Diabetes y Nutricion. 2022 Oct;69(8):648-649. doi: 10.1016/j.endien.2022.10.001. PMID: 36347793

Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain. Palanca A, Quinones Torrelo C, Girbes J, Real JT, Ampudia Blasco FJ. European Journal of Clinical Investigation. 2022 Jun;52(6):e13771. doi: 10.1111/eci.13771. PMID: 35313009

Novel therapies for cardiometabolic disease: recent findings in studies with hormone peptide-derived G protein coupled receptor agonists. Jimenez-Marti E, Hurtado-Genoves G, Aguilar-Ballester M, Martinez-Hervas S, Gonzalez-Navarro H. Nutrients. 2022 Sep 13;14(18):3775. doi: 10.3390/nu14183775. PMID: 36145148

Real-world data of anticoagulant treatment in non-valvular atrial fibrillation. Calderon J, Martinez F, Diaz J, Fernandez A, Sauri I, Uso R, Trillo J, Vela S, Bea C, Redon J, Forner M. Frontiers In Cardiovascular Medicine. 2022 Jan 21;8:733300. doi: 10.3389/fcvm.2021.733300. PMID: 35127843

Real-world evidence of efficacy and safety of SGLT2 inhibitors as adjunctive therapy in adults with Type 1 Diabetes: a European two-center experience. Palanca A, van Nes F, Pardo F, Ampudia Blasco FJ, Mathieu C. Diabetes Care. 2022 Mar 1;45(3):650-658. doi: 10.2337/dc21-1584. PMID: 35061022

Recommendations on the use of telemedicine as applied to nutritional pathology. Abad Gonzalez AL, Civera Andres M, Argente Pla M, Garcia Malpartida K, Olivares Alcolea J, Dominguez Escribano JR, Ferrer Gomez M, Gonzalez Boillos M, Hervas Abad E, Negueruela Avella GI, Urgeles Planella JR, Veses Martin S, Sanchez JC. Nutricion Hospitalaria. 2022 Aug 25;39(4):863-875. doi: 10.20960/nh.03923. PMID: 35312336

SEA 2022 standards for global control of cardiovascular risk. Mostaza J, Pinto X, Armario P, Masana L, Real J, Valdivielso P, Arrobas-Velilla T, Baeza-Trinidad R, Calmarza P, Cebollada J, Civera-Andres M, Cuende Melero J, Diaz-Diaz J, Fernandez Pardo J, Guijarro C, Jerico C, Laclaustra M, Lahoz C, Lopez-Miranda J, Martinez-Hervas S, Muniz-Grijalvo O, Paramo J, Pascual V, Pedro-Botet J, Perez-Martinez P, Plana N, Puzo J, Sanchez Chaparro M, Vila L. Clinica e Investigacion en Arteriosclerosis. 2022 May-Jun;34(3):130-179. doi: 10.1016/j.arteri.2021.11.003. PMID: 35090775

The controversial role of vitamin D in thyroid cancer prevention. Palanca A, Ampudia-Blasco F, Real J. Nutrients. 2022 Jun 23;14(13):2593. doi: 10.3390/nu14132593. PMID: 35807774

Hypercholesterolemic patients have higher eryptosis and erythrocyte adhesion to human endothelium independently of statin therapy. Cilla A, Lopez-Garcia G, Collado-Diaz V, Blanch-Ruiz MA, Garcia-Llatas G, Barbera R, Martinez-Cuesta MA, Real JT, Alvarez A, Martinez-Hervas S. International Journal of Clinical Practice. 2021 Nov;75(11):e14771. doi: 10.1111/ijcp.14771. PMID: 34473881

NT3/TrkC pathway modulates the expression of ucp-1 and adipocyte size in human and rodent adipose tissue. Bove M, Monto F, Guillem-Llobat P, Ivorra M, Noguera M, Zambrano A, Sirerol-Piquer M, Requena A, Garcia-Alonso M, Tejerina T, Real J, Farinas I, D’Ocon P. Frontiers in Endocrinology. 2021 Mar 18;12:630097. doi: 10.3389/fendo.2021.630097. PMID: 33815288

Oral unsaturated fat load impairs postprandial systemic inflammation in primary hypercholesterolemia patients. Collado A, Domingo E, Marques P, Perello E, Martínez-Hervás S, Piqueras L, Ascaso JF, Real JT, Sanz MJ. Frontiers in Pharmacology. 2021 Apr 20;12:656244. doi: 10.3389/fphar.2021.656244. PMID: 33959024

Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: the SAGE study. Wilmot EG, Close KL, Jurisic-Erzen D, Bruttomesso D, Ampudia-Blasco FJ, Bosnyak Z, de Climens AR, Bigot G, Peters AL, Renard E, Berard L, Calliari LE, Seufert J. Diabetes, Obesity & Metabolism. 2021 Aug;23(8):1892-1901. doi: 10.1111/dom.14416. PMID: 33914401

Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes. Ascaso P, Palanca A, Martinez-Hervas S, Sanz MJ, Ascaso JF, Piqueras L, Real JT. International Journal of Clinical Practice. 2021 Aug;75(8):e14302. doi: 10.1111/ijcp.14302. PMID: 33930221

Postprandial triglyceridemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects. Moreno-Perez B, Benito E, Civera M, Alabadi B, Martinez-Hervas S, Peiro M, Gonzalez-Navarro H, Piqueras L, Jesus Sanz M, Ascaso J, Real J. International Journal of Clinical Practice. 2021 Apr;75(4):e13776. doi: 10.1111/ijcp.13776. PMID: 33089594

The nuclear retinoid-related orphan receptor RORalpha controls adipose tissue inflammation in patients with morbid obesity and diabetes. Ortega R, Hueso L, Benito E, Ortega J, Civera M, Sanz M, Real J, Piqueras L. International Journal of Obesity. 2021 Jul;45(7):1369-1381. doi: 10.1038/s41366-021-00787-5. PMID: 33637954

Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents. Ampudia-Blasco F, Palanca A, Trillo J, Navarro J, Real J. Journal of diabetes and its complications. 2021 Mar;35(3):107828. doi: 10.1016/j.jdiacomp.2020.107828. PMID: 33436143

Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia. Aguilar-Ballester M, Hurtado-Genoves G, Taberner-Cortes A, Herrero-Cervera A, Martinez-Hervas S, Gonzalez-Navarro H. International Journal Of Molecular Sciences. 2021 Jan 11;22(2):660. doi: 10.3390/ijms22020660. PMID: 33440821

Time-in-range for monitoring glucose control: Is it time for a change?. Bellido V, Pines-Corrales, PJ, Villar-Taibo R, Ampudia-Blasco FJ. Diabetes Research and Clinical Practice. 2021 Jun 11;177:108917. doi: 10.1016/j.diabres.2021.108917. PMID: 34126129

Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension. Perez-Hernandez J, Riffo-Campos A, Ortega A, Martinez-Arroyo O, Perez-Gil D, Olivares D, Solaz E, Martinez F, Martinez-Hervas S, Chaves F, Redon J, Cortes R. Hypertension. 2021 Mar 3;77(3):960-971. doi: 10.1161/HYPERTENSIONAHA.120.16598. PMID: 33486986